Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
161

Summary

Conditions
Endometrial Cancer
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: double blind placebo controlled studyPrimary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03555422
Collaborators
  • Belgium and Luxembourg Gynaecological Oncology Group
  • North-Eastern German Society of Gynaecologic Oncology
  • Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies
  • Spanish Research Group in Ovarian Cancer
  • Central and Eastern European Gynecologic Oncology Group
  • Israel Society of Gynecologic Oncology
  • The GOG Foundation, Inc.
Investigators
Study Director: Michael Kauffman, MD, PhD Karyopharm Therapeutics Inc